134 related articles for article (PubMed ID: 24916883)
21. Early predictors of clinically significant bleeding in adults with dengue infection.
Chamnanchanunt S; Kanagaraj D; Thanachartwet V; Desakorn V; Rojnuckarin P
Southeast Asian J Trop Med Public Health; 2012 Jul; 43(4):890-9. PubMed ID: 23077811
[TBL] [Abstract][Full Text] [Related]
22. Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability.
Michels M; van der Ven AJ; Djamiatun K; Fijnheer R; de Groot PG; Griffioen AW; Sebastian S; Faradz SM; de Mast Q
Am J Trop Med Hyg; 2012 Nov; 87(5):943-6. PubMed ID: 22949515
[TBL] [Abstract][Full Text] [Related]
23. Expression, localization and systemic concentration of vascular endothelial growth factor (VEGF) and its receptors in patients with ulcerative colitis.
Frysz-Naglak D; Fryc B; Klimacka-Nawrot E; Mazurek U; Suchecka W; Kajor M; Kurek J; Stadnicki A
Int Immunopharmacol; 2011 Feb; 11(2):220-5. PubMed ID: 21115119
[TBL] [Abstract][Full Text] [Related]
24. Complete heart block in dengue complicating management of shock due to both bleeding and leakage: a case report.
Navinan MR; Yudhishdran J; Herath S; Liyanage I; Kugadas T; Kumara D; Kulatunga A
BMC Res Notes; 2015 Mar; 8():68. PubMed ID: 25884693
[TBL] [Abstract][Full Text] [Related]
25. Clinical, laboratory and radiological parameters in children with dengue fever and predictive factors for dengue shock syndrome.
Chacko B; Subramanian G
J Trop Pediatr; 2008 Apr; 54(2):137-40. PubMed ID: 17965098
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.
Wong NS; Buckman RA; Clemons M; Verma S; Dent S; Trudeau ME; Roche K; Ebos J; Kerbel R; Deboer GE; Sutherland DJ; Emmenegger U; Slingerland J; Gardner S; Pritchard KI
J Clin Oncol; 2010 Feb; 28(5):723-30. PubMed ID: 20026801
[TBL] [Abstract][Full Text] [Related]
27. Role of vascular endothelial growth factor (VEGF) in the neurological manifestations of dengue: a preliminary study.
Misra UK; Kalita J; Singh AP
Inflammation; 2014 Apr; 37(2):611-4. PubMed ID: 24292799
[TBL] [Abstract][Full Text] [Related]
28. Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection.
Wiwanitkit V
Clin Appl Thromb Hemost; 2005 Jan; 11(1):112. PubMed ID: 15678283
[No Abstract] [Full Text] [Related]
29. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
30. Hepatic dysfunction in patients infected with dengue virus.
Umar S; Ahmad B; Rana MY; Khan Khattak JZ; Shabbir MI
J Coll Physicians Surg Pak; 2014 Jan; 24(1):74. PubMed ID: 24411552
[No Abstract] [Full Text] [Related]
31. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
32. Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection.
Suwarto S; Sasmono RT; Sinto R; Ibrahim E; Suryamin M
J Infect Dis; 2017 Mar; 215(6):992-999. PubMed ID: 28453844
[TBL] [Abstract][Full Text] [Related]
33. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
[TBL] [Abstract][Full Text] [Related]
34. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.
Molskness TA; Stouffer RL; Burry KA; Gorrill MJ; Lee DM; Patton PE
Hum Reprod; 2004 Apr; 19(4):822-30. PubMed ID: 15033950
[TBL] [Abstract][Full Text] [Related]
36. MMP cellular responses to dengue virus infection-induced vascular leakage.
Luplertlop N; Missé D
Jpn J Infect Dis; 2008 Jul; 61(4):298-301. PubMed ID: 18653973
[TBL] [Abstract][Full Text] [Related]
37. Selected mosquito borne illnesses - Dengue.
McFee RB
Dis Mon; 2018 May; 64(5):246-274. PubMed ID: 29566984
[No Abstract] [Full Text] [Related]
38. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
39. Association Between Soluble Notch Ligand Delta-like Ligand 1 and Bleeding Complications in Patients With Dengue Fever Infection.
Hildebrand D; Nurjadi D; Hoan NX; Linh MTH; Sang VV; Bang MH; Pallerla SR; Kremsner PG; Heeg K; Song LH; Velavan TP
J Infect Dis; 2022 Feb; 225(3):476-480. PubMed ID: 34375432
[TBL] [Abstract][Full Text] [Related]
40. Hemostatic derangement in dengue hemorrhagic fever.
Chuansumrit A; Chaiyaratana W
Thromb Res; 2014 Jan; 133(1):10-6. PubMed ID: 24120237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
